Ubenimex ( DrugBank: Ubenimex )


1 disease
IDDisease name (Link within this page)Number of trials
86Pulmonary arterial hypertension2

86. Pulmonary arterial hypertension


Clinical trials : 1,181 Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02736149
(ClinicalTrials.gov)
December 20164/4/2016Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)A Phase 2, Open-Label, Extension Study to Evaluate the Long-Term Safety and Efficacy of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)Pulmonary Arterial HypertensionDrug: ubenimexEiger BioPharmaceuticalsNULLTerminated18 Years75 YearsAll51Phase 2United States;Canada
2NCT02664558
(ClinicalTrials.gov)
April 201621/1/2016A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)Pulmonary Arterial HypertensionDrug: ubenimex;Other: placeboEiger BioPharmaceuticalsNULLCompleted18 Years75 YearsAll61Phase 2United States;Canada